161 – 170 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial) : A randomised controlled trial
- Contribution to journal › Article
-
Mark
Management of breathlessness in patients with cancer : ESMO Clinical Practice Guidelines †
- Contribution to journal › Article
-
Mark
Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness
- Contribution to journal › Article
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
- Contribution to journal › Article
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
- Contribution to journal › Article
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
- Contribution to journal › Article
-
Mark
Effect of the trajectory of exertional breathlessness on symptom recall and anticipation : A randomized controlled trial
- Contribution to journal › Article
-
Mark
Underlying contributing conditions to breathlessness among middle-aged individuals in the general population : A cross-sectional study
- Contribution to journal › Article
-
Mark
Breathlessness Isn't Cool, But Its Treatment Can Be
- Contribution to journal › Debate/Note/Editorial
